Table 1.

Relationship Between Resistin Expression and Clinicopathological Features in 80 NSCLC Cases

Clinical Case Characteristics	n	Expression Rate of Resistin			χ2	P
		Positive	Negative	Positive Rate (%)
Gender
Male	43	27	16	62.8	2.172	0.175
Female	37	25	12	37.2
Age
>60	39	26	13	66.7	0.986	0.271
≤60	41	26	15	63.4
Histological type
Adenocarcinoma	46	28	18	60.9	2.194	0.085
Squamous cell carcinoma	34	24	10	70.6
Differentiation
Low	14	4	10	28.6	10.112	0.003
Medium and high	66	48	18	52.7
Lymph node metastasis
Yes	58	46	12	79.3	11.267	0.001
No	22	6	16	27.3
TNM staging
Ⅰ	19	4	15	21.1	11.185	0.001
Ⅱ+	61	48	13	78.7